Last checked at 17 Dec 2023 15:16
PRESS: GSK looks for deals in China as rebuilds relationship
(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,733.50
Bid:
1,732.50
Ask:
1,733.00
Change:
0.00 (0.00%)
Spread:
0.50 (0.029%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
1,733.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.DIRECTOR DEALINGS SUMMARY: Glaxo Senior Executive Sells Shares
Fri, 24th Aug 2018 17:01
LONDON (Alliance News) - The following is a summary of director dealings reported in London on Friday.----------GlaxoSmithKline said Friday that Senior Vice President for human resources Claire Thomas sold 30,000 shares in the company.Thomas sold the shares at 1,604.10 pence each for a total consideration of GBP481,230. Shares in the pharmaceutical giant closed up 0.2% at 1,603.00p each.----------C&C Group said Friday that Non-Executive Director Richard Holroyd bought shares worth EUR50,925 in the company. Holroyd acquired 15,000 shares at EUR3.39 each. His total shareholding in the company following the deal was not disclosed. Shares in the alcoholic drinks manufacturer closed up 0.4% at EUR3.42. ----------Premier Asset Management Group said that Senior Independent Director Robert Colthorpe purchased 8,500 shares at a price of 282.50 pence per share on August 6, at a total of GBP24,012. It has not been disclosed how many shares Colthorpe now holds following this transaction. Shares in the asset management group closed 0.6% at 273.50 pence on Friday.----------Byotrol said Friday that Chief Technical Officer Trevor Francis bought shares in the company. Francis acquired 657,686 shares at 3.8 pence each, worth GBP24,992 in total. His total shareholding in the company following the transaction was 2.9 million shares, or 0.68% of the company. Shares in the technology company closed up 3.8% at 3.79p each.----------FTSE 250-listed Electrocomponents said Friday that Chief Executive Officer Lindsley Ruth sold 50,000 shares in the company. Ruth sold the shares at 744.66 pence each in a deal worth GBP372,330. The CEO's total holding in the company after the deal was not disclosed. Shares in the company closed up 0.1% at 754.40p each. ----------Artemis VCT said Friday that two of its non-executive directors acquired shares in the company. Calum Paterson bought 84,966 shares at 66.125 pence each for a total consideration of GBP56,790. Edward Murray purchased 25,000 shares at the same price for GBP16,674. The total shareholding of the directors following the purchases was not disclosed. Shares in the venture capital trust closed up 2.8% at 68.89p each on Friday.----------
More News
15 Dec 2023 17:08
European shares end fifth week higher on rate-cut optimism
Barclays sees first ECB rate cut in April
*Read more15 Dec 2023 16:51
LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools
(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.
Read more15 Dec 2023 16:29
PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg
(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.
Read more12 Dec 2023 10:08
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal
Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.
Read more12 Dec 2023 08:22
TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine
(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.
Read more12 Dec 2023 07:39
LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI
(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.
Read more12 Dec 2023 07:24
GSK seeks to extend RSV vaccine approval in Japan
(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.
Read more11 Dec 2023 08:28
GSK drug gets EU marketing backing for form of endometrial cancer
(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.
Read more11 Dec 2023 07:41
LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook
(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.
Read more11 Dec 2023 07:23
GSK endometrial cancer treatment gets Europe authorisation
(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.
Read more7 Dec 2023 12:54
THG backer Kelso pushes for demerger to trim "inherent" valuation gap
(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.
Read more5 Dec 2023 10:02
LONDON BROKER RATINGS: Goldman lifts Landsec and British Land
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
Read more27 Nov 2023 09:00
GSK announces positive results from Blenrep phase 3 blood cancer trial
(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.
Read more27 Nov 2023 08:02
GSK receives 'positive' headline results from phase III trial
(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.
Read more